A Comparison of Haematological Parameters in a Botswana HIV Cohort in which Cardiovascular Events were Common.

Download Article

DOI: 10.21522/TIJPH.2013.04.02.Art045

Authors : Rumbidzai Angelah Mubeda


The study was a comparison between the haematological profile parameters of Human Immunodeficiency Virus (HIV) positive patients who developed a cardiac event and those who did not. The aim was to assess the possibility of using haematological parameters as predictors of the risk of developing a cardiovascular event in a Botswana HIV positive cohort. Elevated white blood cell (WBC) count, neutrophil (NEUT), CD8 T cell count (CD8) and decreased lymphocyte (LYMPH), CD4 T cell count (CD4) and CD4/CD8 ratio have been associated with cardiovascular risk. Whether this association is present in an HIV positive cohort in Botswana is uncertain. Differences in the haematological parameters of HIV positive patients who developed a cardiac event and of those who did not were compared at 3 different time points using the Mann Whitney U Test. A total of 9 cases and 34 controls were studied. At baseline, cases had higher WBC counts with a mean rank of 25.86 compared to controls (16.04) with p value of 0.012. NEUT mean rank of 24.58 for cases was higher than 13.23 for controls (p=0.002). At 6 months into study and at occurrence of event, the differences were not statistically significant. Study shows that at baseline, WBC and NEUT are higher for patients likely to develop a cardiac event hence can be a potential risk predictor.


[1.] Abu-Zeid, H. A., & Chapman, J. M. (1977). Hemoglobin level and ischemic heart disease: relationship to known risk factors. Prev Med, 6(1), 120–129. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/850674

[2.] AIDS.gov. (n.d.). Just Diagnosed with HIV/AIDS:Overview: Chronic Manageable Disease. Retrieved from Retrieved from https://www.aids.gov/hiv-aids-basics/just-diagnosed-with-hiv-aids/overview/chronic-manageable-disease/

[3.] Anogeianaki, A., Angelucci, D., Cianchetti, E., D’Alessandro, M., Maccauro, G., Saggini, A., … Shaik-Dasthagirisaheb, Y. B. (2011). Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol, 24(4), 817–825. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22230389

[4.] Bhatt, D. L., Chew, D. P., Lincoff, A. M., Simoons, M. L., Harrington, R. A., Ommen, S. R., … Topol, E. J. (2003). Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol, 92(2), 136–140. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12860213

[5.] Burr, M. L., Holliday, R. M., Fehily, A. M., & Whitehead, P. J. (1992). Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J, 13(2), 166–170. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1313369

[6.] Cannon, C. P., McCabe, C. H., Wilcox, R. G., Bentley, J. H., & Braunwald, E. (2001). Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. Am J Cardiol, 87(5), 636–9, A10. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11230853

[7.] Carter, C., McGee, D., Reed, D., Yano, K., & Stemmermann, G. (1983). Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am Heart J, 105(4), 674–679. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/6837420

[8.] Cerrato, E., Calcagno, A., D’Ascenzo, F., Biondi-Zoccai, G., Mancone, M., Grosso Marra, W., … Gaita, F. (2015). Cardiovascular disease in HIV patients: from bench to bedside and backwards. Open Heart, 2(1), e000174. http://doi.org/10.1136/openhrt-2014-000174

[9.] Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013). The end of AIDS: HIV infection as a chronic disease. Lancet, 382(9903), 1525–1533. http://doi.org/10.1016/S0140-6736(13)61809-7

[10.] Deeks, S. G., & Phillips, A. N. (2009). HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ, 338, a3172. http://doi.org/10.1136/bmj.a3172

[11.] Dragu, R., Khoury, S., Huri, S., Zuckerman, R., Suleiman, M., Mutlak, D., … Aronson, D. (2008). Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis, 196(1), 405–12. http://doi.org/10.1016/j.atherosclerosis.2006.11.022

[12.] Eriksson, E. E., Xie, X., Werr, J., Thoren, P., & Lindbom, L. (2001). Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med, 194(2), 205–218. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11457895

[13.] Ernst, E. (1987). Leukocytes and the Risk of Ischemic Diseases. JAMA: The Journal of the American Medical Association, 257(17), 2318. http://doi.org/10.1001/jama.1987.03390170074031

[14.] Farahani, M., Vable, A., Lebelonyane, R., Seipone, K., Anderson, M., Avalos, A., … Marlink, R. (2014). Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis. The Lancet Global Health, 2(1), e44–e50. Retrieved from http://linkinghub.elsevier.com/retrieve/pii/S2214109X13701499

[15.] Freiberg, M. S., Chang, C.-C. H., Kuller, L. H., Skanderson, M., Lowy, E., Kraemer, K. L., … Justice, A. C. (2013). HIV infection and the risk of acute myocardial infarction. JAMA Internal Medicine, 173(8), 614–22. http://doi.org/10.1001/jamainternmed.2013.3728

[16.] Frostegard, J. (2013). Immunity, atherosclerosis and cardiovascular disease. BMC Medicine, 11(1), 117. Retrieved from http://www.biomedcentral.com/1741-7015/11/117

[17.] Fuster, V. (1994). Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology [published erratum appears in Circulation 1995 Jan 1;91(1):256]. Circulation, 90(4), 2126–2146. http://doi.org/10.1161/01.CIR.90.4.2126

[18.] Gebo, K. A. (2006). HIV and aging: implications for patient management. Drugs Aging, 23(11), 897–913. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17109568

[19.] Grzybowski, M., Welch, R. D., Parsons, L., Ndumele, C. E., Chen, E., Zalenski, R., & Barron, H. V. (2004). The Association between White Blood Cell Count and Acute Myocardial Infarction In-hospital Mortality: Findings from the National Registry of Myocardial Infarction. Academic Emergency Medicine, 11(10), 1049–1060. http://doi.org/10.1197/j.aem.2004.06.005

[20.] Hansson, G. K. M. D. P. (2005). MECHANISMS OF DISEASE: Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med, 352(16), 1685–1695. Retrieved from http://search.proquest.com/docview/223931318?accountid=15083

[21.] Harmon, M. (2014a). Excel Master Series Blog: Mann-Whitney U Test in 12 Steps in Excel as 2-Sample Pooled t-Test Nonparametric Alternative in Excel 2010 and Excel 2013. Retrieved September 24, 2015, from http://blog.excelmasterseries.com/2014/05/mann-whitney-u-test-as-2-sample-pooled.html

[22.] Harmon, M. (2014b). Excel Master Series Blog: Sign Test As a 1-Sample t-Test Alternative in Excel 2010 and Excel 2013. Retrieved September 25, 2015, from http://blog.excelmasterseries.com/2014/05/sign-test-as-1-sample-t-test.html

[23.] Haumer, M., Amighi, J., Exner, M., Mlekusch, W., Sabeti, S., Schlager, O., … Schillinger, M. (2005). Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. Journal of Vascular Surgery, 41(4), 610–7. http://doi.org/10.1016/j.jvs.2005.01.013

[24.] Health, M. of (Ed.). (2002). Botswana Guidelines on Antiretroviral Treatment. Gaborone, Botswana.

[25.] Health, M. of (Ed.). (2005). Botswana Guidelines on Antiretroviral Treatment. Gaborone, Botswana.

[26.] Hoffman, M., Blum, A., Baruch, R., Kaplan, E., & Benjamin, M. (2004). Leukocytes and coronary heart disease. Atherosclerosis, 172(1), 1–6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14709350

[27.] Horne, B. D., Anderson, J. L., John, J. M., Weaver, A., Bair, T. L., Jensen, K. R., … Muhlestein, J. B. (2005). Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol, 45(10), 1638–1643. http://doi.org/10.1016/j.jacc.2005.02.054

[28.] Hotchkiss, J. W., & Leyland, A. H. (2011). The relationship between body size and mortality in the linked Scottish Health Surveys: cross-sectional surveys with follow-up. International Journal of Obesity (2005), 35(6), 838–51. http://doi.org/10.1038/ijo.2010.207

[29.] Hyde, J. (2004). Retrospective Cohort Study Strengths and Weaknesses. Retrieved from http://ocw.tufts.edu/Content/1/lecturenotes/194039/194062

[30.] Jonasson, L., Holm, J., Skalli, O., Bondjers, G., & Hansson, G. K. (1986). Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis, Thrombosis, and Vascular Biology, 6(2), 131–138. http://doi.org/10.1161/01.atv.6.2.131

[31.] Kovanen, P. T., Kaartinen, M., & Paavonen, T. (1995). Infiltrates of Activated Mast Cells at the Site of Coronary Atheromatous Erosion or Rupture in Myocardial Infarction. Circulation, 92(5), 1084–1088. http://doi.org/10.1161/01.cir.92.5.1084

[32.] Lang, S., Mary-Krause, M., Simon, A., Partisani, M., Gilquin, J., Cotte, L., … Costagliola, D. (2012). HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 55(4), 600–7. http://doi.org/10.1093/cid/cis489

[33.] Langston, R. D., Presley, R., Flanders, W. D., & McClellan, W. M. (2003). Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int, 64(4), 1398–1405. http://doi.org/10.1046/j.1523-1755.2003.00200.x

[34.] Ledergerber, B., Egger, M., Opravil, M., Telenti, A., Hirschel, B., Battegay, M., … Weber, R. (1999). Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet, 353(9156), 863–868. Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=1645441&site=ehost-live

[35.] Libby, P. (1995). Molecular bases of the acute coronary syndromes. Circulation, 91(11), 2844–2850. http://doi.org/10.1161/01.CIR.91.11.2844

[36.] Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420(6917), 868–74. http://doi.org/10.1038/nature01323

[37.] Libby, P. (2003). Vascular biology of atherosclerosis: overview and state of the art. The American Journal of Cardiology, 91(3A), 3A–6A. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12645637

[38.] Lowe, G. D., Lee, A. J., Rumley, A., Price, J. F., & Fowkes, F. G. (1997). Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol, 96(1), 168–173. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9012704

[39.] Madjid, M., & Fatemi, O. (2013). Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J, 40(1), 17–29. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23467296

[40.] Martinez, E., Milinkovic, A., Buira, E., de Lazzari, E., Leon, A., Larrousse, M., … Gatell, J. M. (2007). Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med, 8(4), 251–258. http://doi.org/10.1111/j.1468-1293.2007.00468.x

[41.] Massberg, S., Brand, K., Grüner, S., Page, S., Müller, E., Müller, I., … Gawaz, M. (2002). A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation. The Journal of Experimental Medicine, 196(7), 887–896. http://doi.org/10.1084/jem.20012044

[42.] Menon, V., Lessard, D., Yarzebski, J., Furman, M. I., Gore, J. M., & Goldberg, R. J. (2003). Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol, 92(4), 368–372. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12914863

[43.] Montaner, J. S., Wood, E., Kerr, T., Lima, V., Barrios, R., Shannon, K., … Hogg, R. (2010). Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes. J Acquir Immune Defic Syndr, 55 Suppl 1, S5–9. http://doi.org/10.1097/QAI.0b013e3181f9c1f0

[44.] Mueller, C., Neumann, F. J., Perruchoud, A. P., & Buettner, H. J. (2003). White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation. Heart, 89(4), 389–392. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12639865

[45.] Mussini, C., Lorenzini, P., Cozzi-Lepri, A., Lapadula, G., Marchetti, G., Nicastri, E., … Monforte, A. d’Arminio. (2015). CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. The Lancet HIV. http://doi.org/10.1016/S2352-3018(15)00006-5

[46.] Olivares, R., Ducimetiere, P., & Claude, J. R. (1993). Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol, 137(1), 49–53. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8434572

[47.] Oluwatosin A. Badejo, Chung-Chou Chang, et al. (2015). CD8+ T-Cells Count in Acute Myocardial Infarction in HIV Disease in a Predominantly Male Cohort. BioMed Research International, 2015, 5. http://doi.org/10.1155/2015/246870

[48.] Ommen, S. R., Gibbons, R. J., Hodge, D. O., & Thomson, S. P. (1997). Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. The American Journal of Cardiology, 79(6), 812–4. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9070569

[49.] Palella Jr., F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006). Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr, 43(1), 27–34. http://doi.org/10.1097/01.qai.0000233310.90484.16

[50.] Panos, G., Samonis, G., Alexiou, V. G., Kavarnou, G. A., Charatsis, G., & Falagas, M. E. (2008). Mortality and morbidity of HIV infected patients receiving HAART: a cohort study. Curr HIV Res, 6(3), 257–260. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18473789

[51.] Prentice, R. L., Szatrowski, T. P., Fujikura, T., Kato, H., Mason, M. W., & Hamilton, H. H. (1982). Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol, 116(3), 496–509. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7124717

[52.] Puddu, P. E., Lanti, M., Menotti, A., Mancini, M., Zanchetti, A., Cirillo, M., & Angeletti, M. (2002). Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population study. Acta Cardiol, 57(3), 177–185. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12088175

[53.] Ross, R. (1999). Atherosclerosis--an inflammatory disease. The New England Journal of Medicine, 340(2), 115–26. http://doi.org/10.1056/NEJM199901143400207

[54.] Sabatine, M. S., Morrow, D. A., Cannon, C. P., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., … Gibson, C. M. (2002). Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservati. J Am Coll Cardiol, 40(10), 1761–1768. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12446059

[55.] Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., … Wissler, R. W. (1995). A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis: A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 92(5), 1355–1374. http://doi.org/10.1161/01.cir.92.5.1355

[56.] Teague, A. (n.d.). HIV: Now a manageable chronic disease. Retrieved from Retrieved from www.pharmacytimes.com/publications/issue/2007/2007.../2007-03-6317

[57.] Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. The Journal of Clinical Endocrinology and Metabolism, 92(7), 2506–12. http://doi.org/10.1210/jc.2006-2190

[58.] Turner, S. J., Ketch, T. R., Gandhi, S. K., & Sane, D. C. (2008). Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Am Heart J, 155(5), 806–816. http://doi.org/10.1016/j.ahj.2007.11.037

[59.] Turner, S. J., Ketch, T. R., Gandhi, S. K., & Sane, D. C. (2008). Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. American Heart Journal, 155(5), 806–16. http://doi.org/10.1016/j.ahj.2007.11.037

[60.] Wester, C. W., Bussmann, H., Koethe, J., Moffat, C., Vermund, S., Essex, M., & Marlink, R. G. (2009). Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. HIV Ther, 3(5), 501–526. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20161344

[61.] Wester, C. W., Kim, S., Bussmann, H., Avalos, A., Ndwapi, N., Peter, T. F., … Marlink, R. (2005). Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr, 40(3), 336–343. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16249709

[62.] Wester, C. W., Koethe, J. R., Shepherd, B. E., Stinnette, S. E., Rebeiro, P. F., Kipp, A. M., … Marlink, R. G. (2011). Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. AIDS, 25(12), 1471–1479. http://doi.org/10.1097/QAD.0b013e328347f9d4

[63.] Wester, C. W., Thomas, A. M., Bussmann, H., Moyo, S., Makhema, J. M., Gaolathe, T., … Marlink, R. G. (2010). Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana. AIDS, 24 Suppl 1, S27–36. http://doi.org/10.1097/01.aids.0000366080.91192.55

[64.] Whitlock, G., Lewington, S., Sherliker, P., Clarke, R., Emberson, J., Halsey, J., … Peto, R. (2009). Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet, 373(9669), 1083–96. http://doi.org/10.1016/S0140-6736(09)60318-4

[65.] Zalokar, J. B., Richard, J. L., & Claude, J. R. (1981). Leukocyte count, smoking, and myocardial infarction. The New England Journal of Medicine, 304(8), 465–8. http://doi.org/10.1056/NEJM198102193040806

[66.] Zouridakis, E. G., Garcia-Moll, X., & Kaski, J. C. (2000). Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol, 86(4), 449–451. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10946041